ƹϵεapp

Adult Kidney Disease: Blood Pressure Management

RETIRED REVIEW: This measure has been retired by the measure steward or is not relevant to internal medicine. This measure will not be re-reviewed by the PMC.

Percentage of patient visits for those patients aged 18 years and older with a diagnosis of chronic kidney disease (CKD) (stage 3, 4, or 5, not receiving Renal Replacement Therapy [RRT]) with a blood pressure < 140/90 mmHg OR >= 140/90 mmHg with a documented plan of care.

Date Reviewed: November 19, 2017
Do Not Support
    Group/Practice Individual Clinician

Measure Info

MIPS 122 CMS 122
Measure Type
Process
Measure Steward
Renal Physicians Association
Clinical Topic Area
Chronic Kidney Disease
Hypertension
Care Setting
Outpatient
Data Source
Registry

ACP does not support QPP 122: “Adult Kidney Disease: Blood Pressure Management.” We cannot estimate the clinical impact based on the information provided by the measure developers and the measure lost NQF endorsement due to a lack of evidence. The ƹϵεapp (ACP) guideline states that there is no difference in outcomes between strict blood pressure control and standard blood pressure control (128-133 mmHg vs. 134- 141 mmHg systolic, and 75-81 mmHg vs. 81-87 mmHg diastolic). Also, the measure specifications do not align with clinical recommendations on disease classification. The Renal Association recommends clinicians stratify stage 3 kidney disease into 2 groups (3a or 3b). Furthermore, the denominator population includes all patients with stage 3 kidney disease and above. It is burdensome for clinicians to document a care plan for all patients classified as stage 3 and above without evidence to support the benefit of the intervention on clinical outcomes.